Clinical Trial Update: Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial updates prevention of non-surgical bleeding in HeartMate II patients without antiplatelet therapy, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• HeartMate II (left ventricular assist device)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2020-10-29